The entrepreneurs behind several innovative health care and biotech companies talked about the challenges and successes of leading their startups during a panel discussion Wednesday at the UWM Innovation Campus.

Health care and biotech entrepreneurs spoke about their success and challenges during a Bridge to Cures event Wednesday.

The event, which was part of Startup Milwaukee Week, was hosted by Bridge to Cures, a Wauwatosa-based nonprofit organization that is focused on bringing health care innovations to market.

The panelists included:

  • Sherry Zhang of GenoPalate Inc., a Brookfield-based company that provides nutrition recommendations for individuals based on a DNA analysis it performs.
  • Kirk Prichard of ReNeuroGen, an Elm Grove-based pharmaceutical company that has developed a therapy that could help reverse the effects of stroke and multiple sclerosis.
  • Nathan Katz of JoinTechLabs, a company that is developing cell-based diagnostic applications for detection of early stage medical indications.
  • Joe McGraw of Microlitics, a company that has developed a diagnostic test that enables personalization of drug treatments based on a patient’s phenotypic makeup.
  • Michael Litman of MedSync-Rx, a company that has developed an app to synchronize medication pick-up schedules for patients with multiple prescriptions.
  • Michael James of Essential Biotechnology, which is developing a cancer-treating drug that inhibits a protein on the surface of tumor cells that is critical to the tumor survival.

Prichard, professor of surgery and vice chair of research for the department of surgery and director of the Translational Vascular Biology Program at the Medical College of Wisconsin, said the key to securing funding has been persistence. Read the full story here.